SCHEMBL14926977

SCHEMBL14926977

N#Cc1nc(-c2cc(-c3ccccc3)cc(-c3ccccc3)c2)cc2cc(CO)c(CO)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SQOR Q9Y6N5 5/20 0.40
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ ADORA2A P29274 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ EGLN2 Q96KS0 1/20 0.35
▸ EGLN1 Q9GZT9 1/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ FLT1 P17948 1/20 0.35
▸ GRK5 P34947 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ MAP2K2 P36507 1/20 0.35
▸ CDK8 P49336 1/20 0.35
▸ GSK3A P49840 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14926980 0.80 ACHE (0.40) MEN1KMT2AL3MBTL1ADORA1PIM1
SCHEMBL127673 0.80 RAC1 (0.40) MEN1KMT2AADORA1POLBALDH1A1
SCHEMBL14926972 0.76 ESR1 (0.39) MEN1KMT2AL3MBTL1ADORA2AMAPK1
SCHEMBL12071506 0.76 SMN1; SMN2 (0.47) SQORMEN1KMT2AADORA1ADORA2A
SCHEMBL15124135 0.75 KMT2A (0.45) SQORMEN1KMT2AL3MBTL1ADORA1
SCHEMBL14903953 0.74 SQOR (0.35) SQORMEN1KMT2AL3MBTL1ADORA1
SCHEMBL128848 0.73 RAC1 (0.42) MEN1KMT2AALDH1A1
SCHEMBL14927014 0.73 L3MBTL1 (0.43) SQORMEN1KMT2AL3MBTL1ADORA1
SCHEMBL14926975 0.73 ADORA3 (0.43) MEN1KMT2AADORA1HPGDALDH1A1
SCHEMBL14926981 0.73 ADORA3 (0.49) MEN1KMT2AADORA1ADORA2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 SQOR 574/4885MEN1 1251/4885KMT2A 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback